DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2006 archives
Click here to return to the current data set

Search for Tradename: benicar

Summary for Tradename: benicar

Patents:2
Applicants:1
NDAs:2
2009 Sales:$526,569,000
Therapeutic Class:Cardiovascular Agents
Glossary
Applicant Tradename Generic Name NDA Approval Date Type RLD Patent Number Patent Expiration Exclusivity Expiration
Daiichi SankyoBENICARolmesartan medoxomil021286Apr 25, 2002RXNoAPR 25,2007
Daiichi SankyoBENICARolmesartan medoxomil021286Apr 25, 2002RXNo5,616,599APR 25,2016
Daiichi SankyoBENICARolmesartan medoxomil021286Apr 25, 2002RXNo6,878,703NOV 19,2021
Export available with Ultimate Plan subscription: 

This preview shows a limited data set. Complete access is available with a Subscription

 

Paragraph IV activity for: BENICAR

Drugname Dosage Strength RLD Submissiondate
olmesartan medoxomil and hydrochlorothiazideTablets20 mg/12.5 mgBenicar HCT5/11/2007
olmesartan medoxomil and hydrochlorothiazideTablets40 mg/12.5 mg and 40 mg/25 mLBenicar HCT2/15/2007
olmesartan medoxomilTablets5 mg, 20 mg and 40 mgBenicar4/25/2006

<- Back to Dashboard


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright © 2000-2010, thinkBiotech LLC.


[ Home | Site Tour | Plan Comparison | Free Patent Expiration Newsletter | Patent Inventor Report | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
Bookmark or Share This Page ...
[del.icio.us] [Digg] [Reddit] [Facebook] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Email]